Ketelsen Dominik, Vogel Wichard, Bethge Wolfgang, Werner Matthias, Dietz Klaus, Claussen Claus D, Horger Marius
Department for Diagnostic and Interventional Radiology, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany.
AJR Am J Roentgenol. 2009 Sep;193(3):W181-5. doi: 10.2214/AJR.08.1953.
The aim of the study was to assess variations in the diameter of the common bile duct in patients with gastrointestinal graft-versus-host disease (GVHD) undergoing abdominal CT after allogeneic hematopoietic stem cell transplantation and to correlate the findings with laboratory results on cholestasis.
We performed a retrospective analysis of the caliber of the common bile duct in 27 adult patients with histologically validated gastrointestinal GVHD who underwent two or more follow-up abdominal CT examinations. Another 25 patients who underwent allogeneic hematopoietic stem cell transplantation during the same period at our institution but who did not have GVHD constituted the control group. The diameters of the common bile duct were correlated with cholestasis values.
A pathologic diameter of the common bile duct was defined as greater than 7 mm (48 patients) in patients who had not undergone cholecystectomy and greater than 8 mm in those who had (four patients). The median diameter of the common bile duct was 7 mm (range, 4-14.8 mm) in the GVHD group and 5.8 mm (range, 3.9-10.2 mm) in the control group. Pathologic diameters of the common bile duct were found in 67% of the patients in the GVHD group and in 12% of the control group (p < 0.0001). The variation coefficient of the diameter of the common bile duct was 12.4% in the GVHD group (83 examinations) and 6.4% in the control group (92 examinations) (p < 0.0001). Ninety-six percent of the patients in the GVHD group had elevated cholestasis values with a significant positive correlation between bilirubin concentration and diameter of the common bile duct (r = 0.421; p = 0.032). Enhancement of the common bile duct and gallbladder wall was seen in the majority of GVHD patients but no controls (p < 0.0001).
Temporary dilatation of the common bile duct seems to be a common finding in gastrointestinal GVHD after hematopoietic stem cell transplantation and correlates with bilirubin concentration. This knowledge of fluctuation in bile duct diameter can help to avoid unnecessary tests to evaluate for pathologic causes of biliary dilatation.
本研究旨在评估异基因造血干细胞移植后接受腹部CT检查的胃肠道移植物抗宿主病(GVHD)患者胆总管直径的变化,并将结果与胆汁淤积的实验室检查结果相关联。
我们对27例经组织学证实患有胃肠道GVHD且接受了两次或更多次腹部CT随访检查的成年患者的胆总管管径进行了回顾性分析。同期在我院接受异基因造血干细胞移植但未患GVHD的另外25例患者作为对照组。将胆总管直径与胆汁淤积值进行关联分析。
未行胆囊切除术的患者,胆总管病理直径定义为大于7mm(48例患者);行胆囊切除术的患者,定义为大于8mm(4例患者)。GVHD组胆总管的中位直径为7mm(范围4 - 14.8mm),对照组为5.8mm(范围3.9 - 10.2mm)。GVHD组67%的患者发现胆总管病理直径,对照组为12%(p < 0.0001)。GVHD组(83次检查)胆总管直径的变异系数为12.4%,对照组(92次检查)为6.4%(p < 0.0001)。GVHD组96%的患者胆汁淤积值升高,胆红素浓度与胆总管直径之间存在显著正相关(r = 0.421;p = 0.032)。大多数GVHD患者可见胆总管及胆囊壁强化,而对照组未见(p < 0.0001)。
造血干细胞移植后胃肠道GVHD患者胆总管暂时扩张似乎是常见表现,且与胆红素浓度相关。了解胆管直径的波动有助于避免为评估胆管扩张的病理原因而进行不必要的检查。